Market open
Balchem/$BCPC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Balchem
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) The Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) The Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia.
Ticker
$BCPC
Sector
Trading on
Industry
Chemicals
Headquarters
Employees
1,300
Website
Balchem Metrics
BasicAdvanced
$5.2B
42.95
$3.73
0.64
$0.87
0.54%
Price and volume
Market cap
$5.2B
Beta
0.64
52-week high
$186.03
52-week low
$137.69
Average daily volume
138K
Dividend rate
$0.87
Financial strength
Current ratio
2.979
Quick ratio
1.775
Long term debt to equity
20.547
Total debt to equity
20.836
Dividend payout ratio (TTM)
21.04%
Interest coverage (TTM)
8.64%
Management effectiveness
Return on assets (TTM)
6.41%
Return on equity (TTM)
11.04%
Valuation
Price to earnings (TTM)
42.949
Price to revenue (TTM)
5.486
Price to book
4.42
Price to tangible book (TTM)
23.83
Price to free cash flow (TTM)
31.826
Dividend yield (TTM)
0.54%
Forward dividend yield
0.54%
Growth
Revenue change (TTM)
1.74%
Earnings per share change (TTM)
17.31%
3-year revenue growth (CAGR)
7.12%
3-year earnings per share growth (CAGR)
9.26%
3-year dividend per share growth (CAGR)
10.85%
What the Analysts think about Balchem
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Balchem stock.
Balchem Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Balchem Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Balchem News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Balchem stock?
Balchem (BCPC) has a market cap of $5.2B as of January 27, 2025.
What is the P/E ratio for Balchem stock?
The price to earnings (P/E) ratio for Balchem (BCPC) stock is 42.95 as of January 27, 2025.
Does Balchem stock pay dividends?
Yes, the Balchem (BCPC) stock pays dividends to shareholders. As of January 27, 2025, the dividend rate is $0.87 and the yield is 0.54%. Balchem has a payout ratio of 21.04% on a trailing twelve-month basis.
When is the next Balchem dividend payment date?
The next Balchem (BCPC) dividend payment date is unconfirmed.
What is the beta indicator for Balchem?
Balchem (BCPC) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.